HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jain, D. Articles by Zaret, B. L. Search for Related Content PubMed PubMed Citation Articles by Jain, D. Articles by Zaret, B. L.

Biokinetics of Technetium-99m-Tetrofosmin: Myocardial Perfusion Imaging Agent: Implications for a One-Day Imaging Protocol

Section of Cardiovascular Medicine, Department of Internal Medicine and Cardiovascular Nuclear Imaging Laboratory, Yale University School of Medicine, New Haven, Connecticut

Correspondence: For correspondence contact: Barry L. Zaret, MD, Robert W. Berliner Professor of Medicine, Chief Section of Cardiovascular Medicine, 3 FMP, Yale University School of Medicine, 333 Cedar St., New Haven CT 06510.

Correspondence: For reprints contact: Diwakar Jain, MD, Section of Cardiovascular Medicine, 3 FMP, Yale University School of Medicine, 333 Cedar St., New Haven CT 06510.

ABSTRACT

Tetrofosmin is a ^99mTc-labeled myocardial perfusion imaging agent that has shown encouraging results in Phase I and II clinical trials. The purpose of this study was to determine the biokinetics of this agent following administration during exercise and at rest in order to determine an optimal imaging protocol. Twenty patients with suspected coronary artery disease underwent symptom-limited treadmill exercise. Six to 8 mCi of ^99mTc-tetrofosmin was injected at peak exercise and 22–24 mCi was injected 4 hr later at rest. Serial 5-min planar images were obtained in the left anterior oblique view at 5, 10, 15, 30, 60, 120 and 180 min after the radiotracer injection. Regions of interest were drawn on the serial images around the entire heart and portions of liver, lung, spleen, gallbladder and gastrointestinal tract. Average decay-corrected counts per pixel in each organ were plotted against time. In addition, heart-to-adjacent organ ratios were also determined. On stress images, the heart had the highest activity at all times, with the exception of gallbladder in the first 15 min. On rest images, the gallbladder, liver and gastrointestinal tract initially had higher activity than the heart; but the activity in these organs cleared rapidly over the subsequent 30–60 min. Heart-to-adjacent organ ratios were >1.0 at all times in the stress images. Heart-to-organ ratios were <1.0 in the first 15 min on the rest images for the liver and gastrointestinal tract. However, 30 min later, all ratios on the rest images were 1.0. Technetium-99m-tetrofosmin images were considered to be of good to excellent quality with good myocardial delineation and adequate contrast between the heart and background. These observations indicate that a convenient one-day tetrofosmin imaging protocol similar in duration to conventional ²⁰¹Tl imaging is feasible.

This article has been cited by other articles:

				A. Giorgetti, M. Rossi, M. Stanislao, G. Valle, P. Bertolaccini, A. Maneschi, R. Giubbini, M. L. De Rimini, M. Mazzanti, M. Cappagli, et al. Feasibility and Diagnostic Accuracy of a Gated SPECT Early-Imaging Protocol: A Multicenter Study of the Myoview Imaging Optimization Group J. Nucl. Med., October 1, 2007; 48(10): 1670 - 1675. [Abstract] [Full Text] [PDF]

				S. Borges-Neto, R. H. Tuttle, L. K. Shaw, W. T. Smith IV, D. Jain, R. E. Coleman, and D. Whellan Outcome Prediction in Patients at High Risk for Coronary Artery Disease: Comparison between 99mTc Tetrofosmin and 99mTc Sestamibi Radiology, July 1, 2004; 232(1): 58 - 65. [Abstract] [Full Text] [PDF]

				H. Iida, T. Hayashi, S. Eberl, and H. Saji Quantification in SPECT Cardiac Imaging J. Nucl. Med., January 1, 2003; 44(1): 40 - 42. [Full Text] [PDF]

				E. Chammas, A. Yatim, C. Hage, K. Sokhn, W. Tarcha, and G. Ghanem Evaluation of Tc-99m Tetrofosmin Scan for Coronary Artery Disease Diagnosis Asian Cardiovasc Thorac Ann, September 1, 2002; 10(3): 244 - 247. [Abstract] [Full Text] [PDF]

				N. G. Fisher, H. Leong-Poi, T. Sakuma, S.-J. Rim, J. P. Bin, and S. Kaul Detection of coronary stenosis andmyocardial viability using a singleintravenous bolus injection of BR14 J. Am. Coll. Cardiol., February 6, 2002; 39(3): 523 - 529. [Abstract] [Full Text] [PDF]

				C Anagnostopoulos, M Y Henein, and S R Underwood Non-invasive investigations: Ischaemic heart disease Br. Med. Bull., October 1, 2001; 59(1): 29 - 44. [Abstract] [Full Text] [PDF]

				C Anagnostopoulos and S R Underwood Cardiac imaging Imaging, September 1, 2001; 13(3): 155 - 163. [Abstract] [Full Text] [PDF]

				M. G. Gunning, C. Anagnostopoulos, C. J. Knight, J. Pepper, E. D. Burman, G. Davies, K. M. Fox, D. J. Pennell, P. J. Ell, and S. R. Underwood Comparison of 201Tl, 99mTc-Tetrofosmin, and Dobutamine Magnetic Resonance Imaging for Identifying Hibernating Myocardium Circulation, November 3, 1998; 98(18): 1869 - 1874. [Abstract] [Full Text] [PDF]

				B. L. Zaret, P. Rigo, F. J.T. Wackers, R. C. Hendel, S. H. Braat, A. S. Iskandrian, B. S. Sridhara, D. Jain, R. Itti, A. N. Serafini, et al. Myocardial Perfusion Imaging With 99mTc Tetrofosmin : Comparison to 201Tl Imaging and Coronary Angiography in a Phase III Multicenter Trial Circulation, January 15, 1995; 91(2): 313 - 319. [Abstract] [Full Text]

				D. D. Miller The Growing Flood of Technetium-99m Myocardial Perfusion Agents : More Water . . . or More Mud? Circulation, January 15, 1995; 91(2): 555 - 558. [Abstract] [Full Text]